Quantification of cytotoxic T-cell gene transcripts in human lung transplantation

Transplantation

Volumn 69, Issue 9, 2000, Pages 1923-1927

  Soccal, Paola M ^a   Doyle, Ramona L ^a   Jani, Alkesh ^b   Chang, Stella ^b   Akindipe, Olufemi A ^a   Poirier, Charles ^a   Pavlakis, Martha ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GRANZYME B; PERFORIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC TRANSCRIPTION; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN CELL; LUNG INFECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034658498     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200005150-00030     Document Type: Article

References (36)

1. Tazelaar HD, Nilsson FN, Rinaldi M, Mutagh P, McDougall JC, McGregor CGA. The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection. J Thorac Cardiovasc Surg 1993; 105: 674.
2. Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest 1992; 102: 1049.
3. Scott JP, Fradet G, Smyth RL, et al. Prospective study of transbronchial biopsies in the management of heart-lung and single-lung transplant patients. J Heart Lung Transplant 1991; 10: 626.
4. Higenbottam TW, Stewart S, Penketh A, Wallwork J. Transbronchial biopsy for the diagnosis of rejection in heart-lung transplant recipients. Transplantation 1984; 46: 532.
5. Aarnio P, Ikonen T, Fyhrquist F, Taskinen E, Harjula A. Raised endothelin content in broncho alveolar fluid during allograft rejection in pigs. Scand Cardiovasc J 1998; 32: 301.
6. Clelland C, Higenbottam TW, Stewart S, et al. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients: studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis 1993; 147: 1386.
7. Crim C, Keller CA, Dunphy CH, Maluf HM, Ohar JA. Flow cytometric analysis of lung lymphocytes in lung transplant recipients. Am J Respir Crit Care Med 1996; 153: 1041.
8. Rao PN, Zeevi A, Snyder J, et al. Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. J Heart Lung Transplant 1994; 13: 958.
9. Rizzo M, Sundaresan S, Lynch J, et al. Increased concentrations of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts. J Heart Lung Transplant 1997; 16: 1135.
10. Ross DJ, Yeh AY, Nathan SD, et al. Differential soluble interleukin-2-R levels in bilateral bronchoalveolar lavage after lung transplantation. J Heart Lung Transplant 1994; 13: 972.
11. Clément M-V, Legros-Maida S, Israël-Biet D, et al. Perform and granzyme B expression is associated with severe acute rejection. Transplantation 1994; 57: 322.
12. Humbert M, Devergne O, Cerrina J, et al. Activation of macrophages and cytotoxic cells during cytomegalovirus pneumonia complicating lung transplantations. Am Rev Respir Dis 1992; 145: 1178.
13. Humbert M, Magnan A, Le Roy Ladurie F, et al. Perform and granzyme B gene-expressing cells in bronchoalveolar lavage fluids from lung allograft recipients displaying cytomegalovirus pneumonitis. Transplantation 1994; 57: 1289.
14. Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998; 161: 1758.
15. Yousem SA. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996; 15: 1.
16. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
17. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
18. Sehgal PB, Hefgott DC, Santhanam U, et al. Regulation of the acute phase and immune responses in viral disease: enhanced expression of the beta-2 interferon/hepatocyte-stimulating factor/ interleukin-6 gene in virus infected human fibroblasts. J Exp Med 1988; 167: 1951.
19. Emilie D, Peuchaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-1 replicating lymph nodes. J Clin Invest 1990; 86: 148.
20. Iwamoto GK, Monick MM, Clark BD, Auron PE, Stinski MF, Hunninghake GW. Modulation of interleukin-1-beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest 1990; 85: 1853.
21. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression. J Clin Invest 1994; 93: 474.
22. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes. Am J Respir Cell Mol Biol 1991; 5: 292.
23. Geist LJ, Hunninghake GW. Cytokine gene regulation by viral gene products. J Lab Clin Med 1995; 126: 517.
24. Baithesen M, Messerle M, Reddehase MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 72: 2059.
25. Fuginami RS, Nelson JA, Walker L, Oldstone MBA. Sequence homology and immunologic cross reactivity of human cytomegalovirus with HLA-Dr beta chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100.
26. Legros-Maida S, Soulié A, Benvenuit C, et al. Granzyme B and perform can be used as predictive markers of acute rejection in heart transplantation. Eur J Immunol 1994; 24: 229.
27. Clément MV, Soulié A, Legros-Maida S, et al. Perform and granzyme B: predictive markers for acute GVHD or cardiac rejection after bone marrow or heart transplantation. Nouv Rev Fr Hematol 1991; 33: 465.
28. Krams SM, Villanueva JC, Quinn MB, Martinez OM. Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection. Transpl Immunol 1995; 3: 162.
29. Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562.
30. McDiarmid SV, Farmer DG, Kuniyoshi JS, et al. Perform and granzyme B. Cytolytic proteins up-regulated during rejection of rat small intestine allografts. Transplantation 1995; 59: 762.
31. Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death-differential intrarenal expression of Fas-ligand, Fas, granzyme B, and perform during acute and/or chronic rejection of human renal allografts. Transplantation 1996; 62: 1860.
32. Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 1997; 76: 81.
33. Tannapfel A, Kohlhaw K, Schwarz R, et al. Apoptosis and expression of Fas and Fas-ligand antigen after orthotopic liver transplantation. Transplant Proc 1998; 30: 2358.
34. Seino K, Kayagaki N, Bashuda H, Okumura K, Yagita H. Contribution of Fas-ligand to cardiac allograft rejection. Int Immunol 1996; 8: 1347.
35. Kanda Y, Tanaka Y, Shirakawa K, et al. Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease. Bone Marrow Transplant 1998; 22: 751.
36. Borson ND, Strausbauch MA, Kennedy RB, Oda RP, Landers JP, Wettstein PJ. Temporal sequence of transcription of perforin, Fas-ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts. Transplantation 1999; 67: 672.